• SENSEX
    NIFTY 50
Healthcare

Biocon receives 2 USFDA observations for API unit in Bengaluru

Updated : February 27, 2020 09:25 AM IST

The company said that it would respond to the drug regulator with a corrective and preventive action plan in a timely manner.
“We remain committed to global standards of quality and compliance,” the company’s spokesperson said in the statement.
Biocon receives 2 USFDA observations for API unit in Bengaluru

You May Also Like

Live TV
Advertisement